Ategra Capital Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Ategra Capital Management, LLC

  • $151 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Feb 13, 2025
SELL
$143.31 - $247.0 $1.15 Million - $1.97 Million
-7,990 Closed
0 $0
Q3 2023

Feb 13, 2025
SELL
$170.77 - $211.65 $341 - $423
-2 Reduced 0.03%
7,990 $1.42 Billion
Q2 2023

Feb 13, 2025
BUY
$185.01 - $212.05 $1.48 Million - $1.69 Million
7,992 New
7,992 $1.52 Billion

Others Institutions Holding ALNY

# of Institutions
667
Shares Held
112M
Call Options Held
839K
Put Options Held
771K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.8B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Ategra Capital Management, LLC Portfolio

Follow Ategra Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ategra Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ategra Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email